Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:618-629

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Doetschman, T.
Right arrow Articles by Coffin, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Doetschman, T.
Right arrow Articles by Coffin, J. D.

Hypertension, Vol 22, 618-629, Copyright © 1993 by American Heart Association


ARTICLES

Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders

T Doetschman, M Shull, A Kier and JD Coffin
Department of Molecular Genetics, University of Cincinnati College of Medicine, Ohio 45267-0524.

To better understand the formation of the cardiovascular system and its disease states, models amenable to manipulation must be developed. In this article we present two models. One is a small animal model for an inflammatory disorder that can lead to heart failure. Production of this model is based on the ability of blastocyst-derived embryonic stem cells, which can be genetically altered in vitro by a technique called gene targeting, to reconstitute an entire animal when reintroduced into a blastocyst and allowed to colonize the germ line of the resulting chimeric embryo. The other model is based on the capacity of embryonic stem cells to differentiate in culture into embryo-like structures called embryoid bodies. Embryoid bodies contain angioblasts, or prevascular endothelial cells, which can be induced to undergo aspects of vascular development by manipulation of culture conditions.


This article has been cited by other articles:


Home page
CirculationHome page
Z. Li, J. C. Wu, A. Y. Sheikh, D. Kraft, F. Cao, X. Xie, M. Patel, S. S. Gambhir, R. C. Robbins, J. P. Cooke, et al.
Differentiation, Survival, and Function of Embryonic Stem Cell Derived Endothelial Cells for Ischemic Heart Disease
Circulation, September 11, 2007; 116(11_suppl): I-46 - I-54.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Parisi, D. D'Andrea, C. T. Lago, E. D. Adamson, M. G. Persico, and G. Minchiotti
Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells
J. Cell Biol., October 27, 2003; 163(2): 303 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. J. Goldenthal and J. Marin-Garcia
Stem cells and cardiac disorders: an appraisal
Cardiovasc Res, May 1, 2003; 58(2): 369 - 377.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Yang, J.-Y. Min, J. S. Rana, Q. Ke, J. Cai, Y. Chen, J. P. Morgan, and Y.-F. Xiao
VEGF enhances functional improvement of postinfarcted hearts by transplantation of ESC-differentiated cells
J Appl Physiol, September 1, 2002; 93(3): 1140 - 1151.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
L. Reinlib and L. Field
Cell Transplantation as Future Therapy for Cardiovascular Disease? : A Workshop of the National Heart, Lung, and Blood Institute
Circulation, May 9, 2000; 101 (18): e182 - e187.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
W. Mueller-Klieser
Three-dimensional cell cultures: from molecular mechanisms to clinical applications
Am J Physiol Cell Physiol, October 1, 1997; 273(4): C1109 - C1123.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Vittet, T. Buchou, A. Schweitzer, E. Dejana, and P. Huber
Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structures in embryoid bodies
PNAS, June 10, 1997; 94(12): 6273 - 6278.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
H Weiler-Guettler, W. Aird, H Rayburn, M Husain, and R. Rosenberg
Developmentally regulated gene expression of thrombomodulin in postimplantation mouse embryos
Development, July 1, 1996; 122(7): 2271 - 2281.
[Abstract] [PDF]


Home page
DevelopmentHome page
T. Schlaeger, Y Qin, Y Fujiwara, J Magram, and T. Sato
Vascular endothelial cell lineage-specific promoter in transgenic mice
Development, January 4, 1995; 121(4): 1089 - 1098.
[Abstract] [PDF]